Study summary
An aldosterone synthase blocker lowered hard-to-treat blood pressure
15.7mm Hg drop in systolic blood pressure with 2 mg, vs 5.8 with placebo
What was tested
Baxdrostat, a pill that blocks the body from making aldosterone, against placebo in uncontrolled or resistant high blood pressure. The same drug class as vicadrostat, now tested in diabetes.
What they found
- Systolic blood pressure fell 15.7 mm Hg with the 2 mg dose vs 5.8 with placebo over 12 weeks.
- High potassium was the main side effect to watch.
What it means
Aldosterone synthase inhibitors are being tested to protect the heart and kidneys in diabetes.
Last reviewed 2026-11-16 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.